retatrutide type 2 diabetes trial results 2024 2025 π¨Breaking: Retatrutide's first Phase 3 T2D data just dropped. βΈ A1C: β2.0% at 40 weeks βΈ Weight: β36.6 lbs (β16.8%) at 12 mg βΈ No weight loss plateau β curve still descending Retatrutide Results: 28.3% Weight Loss
Description
30 The most common side effects of octreotide are diarrhea and abdominal pain

Efficacy of semaglutide versus liraglutide in clinical practice
10.1007/s00125-009-1515-4 28 NadolskyK
01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)
The Patient Journey: What to Expect with GLP-1 Treatment Starting GLP-1 therapy is more than just receiving an injection its a structured journey with clear stages
